Exemplos de uso de When co-administered em Inglês e suas traduções para o Português
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Official/political
When co-administered with.
Tudy was 50 mg when co-administered in.
When co-administered with dolutegravir 50mg BID.
No dose adjustment of Vitekta is required when co-administered.
Is increased when co-administered with cobicistat.
The peak concentration of digoxin is increased when co-administered with Tybost.
When co-administered with dolutegravir 50mg once daily.
Concentrations may be increased when co-administered with Kaletra.
When co-administered with dolutegravir 50mg twice daily.
Edatives/hypnotics may be increased when co-administered with EVOTAZ.
When co-administered with a statin, the median apparent half-life of alirocumab was 12 days.
Dose adjustment of Viramune is not required when co-administered with lopinavir.
When co-administered with Harvoni, a reduced dose of statins should be considered and careful monitoring for statin adverse reactions should be undertaken see section 4.4.
Olanzapine showed no interaction when co-administered with lithium or biperiden.
When co-administered with Epclusa, careful monitoring for statin adverse reactions should be undertaken and a reduced dose of statins should be considered if required.
Edoxaban should be used with caution when co-administered with P-gp inducers.
When co-administered with moderate inhibitors of CYP3A(e.g., fluconazole, erythromycin), the Kalydeco dose is as above recommended, but administered once daily see sections 4.4 and 4.5.
Dose adjustment of Nevirapine Teva is not required when co-administered with lopinavir.
Boceprevir exposure was reduced when co-administered with ritonavir-boosted lopinavir or ritonavir-boosted darunavir.
Neuroleptics metabolized by CYP3A or CYP2D6 may be required when co-administered with.
Concentrations may be affected when co-administered with Kaletra due to CYP2C9 induction.
Concentrations of itraconazole, fluconazole andposaconazole may be increased when co-administered with cobicistat.
Vitekta is indicated for use only when co-administered with ritonavir as a boosting agent.
No significant effect on lamivudine and zidovudine concentrations was observed when co-administered with atazanavir.
Dosage reduction of desipramine is recommended when co-administered with ritonavir dosed as an antiretroviral agent.
Isavuconazole can be considered a moderate inhibitor of CYP3A4/5, andsystemic exposure to medicinal products metabolised by CYP3A4 may be increased when co-administered with CRESEMBA.
Warfarin concentrations may be affected when co-administered with boosted PREZISTA.
Systemic exposure to medicinal products metabolised by CYP2B6 may be decreased when co-administered with CRESEMBA.
Concentrations of warfarin may be affected when co-administered with Invirase/ritonavir.
Cyclosporin, sirolimus(rapamycin) and tacrolimus:concentrations may be increased when co-administered with Kaletra.